Mon, November 16, 2009
Sun, November 15, 2009
Fri, November 13, 2009
Thu, November 12, 2009
Wed, November 11, 2009
Tue, November 10, 2009
Mon, November 9, 2009
Sun, November 8, 2009
Sat, November 7, 2009
Fri, November 6, 2009
Thu, November 5, 2009
[ Thu, Nov 05th 2009 ]: Market Wire
Director Resigns From Board
Wed, November 4, 2009
Tue, November 3, 2009

Tekmira Pharmaceuticals Conference Call Advisory


  Copy link into your clipboard //business-finance.news-articles.net/content/200 .. ra-pharmaceuticals-conference-call-advisory.html
  Print publication without navigation Published in Business and Finance on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 9, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that it will hold a conference call and webcast on Thursday November 12, 2009 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to discuss third quarter 2009 operating results and to provide a corporate update.

About the Conference Call

To participate in the conference call, please dial 416-695-6617 or 1-800-355-4959. The call will be available for replay until November 26, 2009 by calling 416-695-5800 or 1-800-408-3053 and entering the code 2875305.

The live or archived webcast can also be accessed through the Company's website at [ www.tekmirapharm.com ].

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at [ www.tekmirapharm.com ]. Tekmira is based in Vancouver, B.C.




Publication Contributing Sources